Welcome to CDC Stacks | Multidrug-Resistant Tuberculosis - 36767 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Multidrug-Resistant Tuberculosis
Filetype[PDF - 32.34 KB]


Details:
No Related Documents.
You May Also Like:
  1. Multidrug-resistant Tuberculosis Detection, Latvia
    Personal Author:
    Skenders, Girts; Fry, Alicia M.; Prokopovica, Inga; Greckoseja, Silvija; Broka, Lonija; Metchock, Beverly; Holtz, Timothy H.; Wells, Charles D.; Leimane, Vaira;
    Published:
    Sep 2005
    Source:
    Emerg Infect Dis. 11(9):1461-1463.
    Description:
    To improve multidrug-resistant tuberculosis (MDR-TB) detection, we successfully introduced the rpoB gene mutation line probe assay into the national laboratory in Latvia, a country with epidemic MDR-TB. The assay detected rifampin resistance with 91%...
    File Type:
    Filetype[PDF - 52.80 KB]
  2. Multidrug-resistant tuberculosis; (MDR TB)
    Corporate Author:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination.
    Published:
    May 2012
    Series:
    TB elimination
    Description:
    Tuberculosis (TB) is a disease caused by bacteria that are spread from person to person through the air. TB usually affects the lungs, but it can also affect other parts of the body, such as the brain, the kidneys, or the spine. In most cases, TB is ...
    File Type:
    Filetype[PDF - 380.91 KB]
  3. Multidrug-resistant tuberculosis; (MDR TB)
    Corporate Author:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination.
    Published:
    April 2010
    Series:
    TB elimination
    Description:
    "Multidrug-resistant TB (MDR TB) is TB that is resistant to at least two of the best anti-TB drugs, isoniazid and rifampicin. These drugs are considered first-line drugs and are used to treat all persons with TB disease." - p. 1
    File Type:
    Filetype[PDF - 279.19 KB]
  4. Characteristics of multidrug-resistant tuberculosis in Namibia
    Personal Author:
    Ricks, Philip M; Mavhunga, Farai; Modi, Surbhi; Indongo, Rosalia; Zezai, Abbas; Lambert, Lauren A; DeLuca, Nick; Krashin, Jamie S; Nakashima, Allyn K; Holtz, Timothy H;
    Published:
    Dec 29 2012
    Source:
    BMC Infect Dis. 2012; 12:385.
    Description:
    Background : To describe the epidemiology and possible risk factors for the development of multidrug-resistant tuberculosis (MDR-TB) in Namibia. : Methods : Using medical records and patient questionnaires, we conducted a case-control study among pat...
    File Type:
    Filetype[PDF - 198.21 KB]
  5. Multidrug-Resistant Tuberculosis in Europe, 2010–2011
    Personal Author:
    Günther, Gunar; van Leth, Frank; Alexandru, Sofia; Altet, Neus; Avsar, Korkut; Bang, Didi; Barbuta, Raisa; Bothamley, Graham; Ciobanu, Ana; Crudu, Valeriu; Davilovits, Manfred; Dedicoat, Martin; Duarte, Raquel; Gualano, Gina; Kunst, Heinke; de Lange, Wiel; Leimane, Vaira; Magis-Escurra, Cecile; McLaughlin, Anne-Marie; Muylle, Inge; Polcová, Veronika; Pontali, Emanuele; Popa, Christina; Rumetshofer, Rudolf; Skrahina, Alena; Solodovnikova, Varvara; Spinu, Victor; Tiberi, Simon; Viiklepp, Piret; Lange, Christoph;
    Corporate Author:
    TBNET
    Published:
    Mar 2015
    Source:
    Emerg Infect Dis. 21(3):409-416.
    Description:
    Drug-resistant Mycobacterium tuberculosis is challenging elimination of tuberculosis (TB). We evaluated risk factors for TB and levels of second-line drug resistance in M. tuberculosis in patients in Europe with multidrug-resistant (MDR) TB. A total ...
    File Type:
    Filetype[PDF - 495.89 KB]